USTR Objects to Japan’s Annual Drug Repricing Plan, Market Expansion Repricing
This article was originally published in PharmAsia News
You may also be interested in...
Japan's MHLW Enhances Role Of Innovation In Drug Pricing, USTR Says
WASHINGTON - Japan is giving more weight to innovation when pricing new drugs
Japan's MHLW Enhances Role Of Innovation In Drug Pricing, USTR Says
WASHINGTON - Japan is giving more weight to innovation when pricing new drugs
Japan's Health Ministry Improves Drug Pricing For Innovators
Japanese agency creates new anti-cancer drugs division and adds personnel to speed up drug reviews, U. S. Trade Representative reports.